Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06745895 · ClinicalTrials.gov registry record · NA
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
A NA study of Colorectal Cancer Screening and Hepatitis C Virus, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06745895: Recruiting NA study of Colorectal Cancer Screening and Hepatitis C Virus, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT06745895 is a NA study of Colorectal Cancer Screening and Hepatitis C Virus that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 350 participants, below the 5,864-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06745895, a NA study of Colorectal Cancer Screening and Hepatitis C Virus, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.
Primary Outcome
Screening Uptake will be measured by the number of participants who complete both CRC and HCV screening documented via Electronic Health Record (EHR) at 12 months post-intervention.
Conditions Studied
Interventions
- BEHAVIORAL MATCHES
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What NCT06745895 shows while recruiting
NCT06745895 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 5,864-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which MATCHES is the first listed.
NCT06745895 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06745895 about?
NCT06745895 is a clinical study titled "Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening". This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.
What is the current status of trial NCT06745895?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-10-21. Estimated completion is 2028-04-30.
What conditions does trial NCT06745895 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening, Hepatitis C Virus.
What interventions are being tested in trial NCT06745895?
The interventions under investigation include: MATCHES (BEHAVIORAL).
Who is sponsoring clinical trial NCT06745895?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06745895 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06745895's enrollment target sits among peer trials
350 11th of 19 higher than 9 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Test Up Now Education Program
COMPLETED · NA
-
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
COMPLETED · NA
-
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI